GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Price-to-Tangible-Book

Valeo Pharma (Valeo Pharma) Price-to-Tangible-Book : (As of May. 02, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Price-to-Tangible-Book?

As of today (2024-05-02), Valeo Pharma's share price is $0.03432. Valeo Pharma's Tangible Book per Share of Jan. 2024 for the quarter that ended in Jan. 2024 was $-0.45. Hence, Valeo Pharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Valeo Pharma's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, Valeo Pharma's highest Price to Tangible Book Ratio was 20.00. The lowest was 20.00. And the median was 20.00.

VPHIF's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.34
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Valeo Pharma's share price is $0.03432. Valeo Pharma's Book Value per Sharefor the quarter that ended in Jan. 2024 was $-0.36. Hence, Valeo Pharma's P/B Ratio of today is .


Valeo Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Valeo Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Price-to-Tangible-Book Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - - -

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Valeo Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valeo Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Price-to-Tangible-Book falls into.



Valeo Pharma Price-to-Tangible-Book Calculation

Valeo Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jan. 2024 )
=0.03432/-0.451
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Valeo Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma (Valeo Pharma) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.